Hemoglobin inhibits endothelium-dependent relaxation to acetylcholine in human coronary arteries in vivo.
- 1 January 1993
- journal article
- abstracts
- Published by Wolters Kluwer Health in Circulation
- Vol. 87 (1) , 80-85
- https://doi.org/10.1161/01.cir.87.1.80
Abstract
BACKGROUND The endothelium can regulate vascular tone by releasing both endothelium-derived relaxing factor (EDRF or nitric oxide) and contracting factors. To date, there has only been circumstantial evidence to indicate EDRF activity in vivo in human coronary arteries. Using human hemoglobin as a specific inhibitor, the hypothesis that acetylcholine-induced coronary vasodilation is due to EDRF release was tested. METHODS AND RESULTS We studied the response of normal coronary arteries to acetylcholine (an endothelium-dependent vasodilator) and isosorbide dinitrate (an endothelium-independent vasodilator) in seven patients. The specificity of any vasodilator response was assessed by the infusion of reduced free human hemoglobin. Hemoglobin 10(-5) M infusion alone had no effect on coronary artery diameter. Drugs were infused into the coronary artery, and the diameter changes were assessed by quantitative angiography. Acetylcholine 10(-7) M increased left anterior descending coronary artery diameter from control: 2.30 +/- 0.12 mm to 2.79 +/- 0.20 mm (mean +/- SEM, n = 7, p < 0.01). Hemoglobin both in a concentration of 10(-6) M and 10(-5) M reversed this vasodilator effect, causing constriction to 2.11 +/- 0.18 mm (p < 0.001 compared with acetylcholine 10(-7) M) and 2.29 +/- 0.14 mm (p < 0.05 compared with acetylcholine 10(-7) M). Isosorbide dinitrate in the presence of hemoglobin caused dilatation of the coronary artery in all cases to 3.04 +/- 0.24 mm (p < 0.001 compared with acetylcholine 10(-7) M and hemoglobin 10(-6) M). CONCLUSIONS Using a specific inhibitor of nitric oxide, reduced free hemoglobin, we have demonstrated that basal EDRF release does not appear to play an important role in the maintenance of human epicardial coronary artery diameter in vivo but is responsible for the acetylcholine-induced dilatation.Keywords
This publication has 25 references indexed in Scilit:
- Large coronary arteries in humans are responsive to changing blood flow: An endothelium-dependent mechanism that fails in patients with atherosclerosisJournal of the American College of Cardiology, 1990
- Coronary Vasoconstrictor Activity of Purified and Modified Human HemoglobinBiomaterials, Artificial Cells and Artificial Organs, 1990
- Hemoglobin causes both endothelium-dependent and endothelium-independent contraction of the pig coronary arteries, independently of an inhibition of EDRF effectsCellular and Molecular Life Sciences, 1989
- Effects of acetylcholine on epicardial coronary arteries after cardiac transplantation without angiographic evidence of fixed graft narrowingThe American Journal of Cardiology, 1988
- Effects of intracoronary injection of acetylcholine on coronary arterial hemodynamics and diameterThe American Journal of Cardiology, 1988
- Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasmJournal of the American College of Cardiology, 1988
- Differences in Basal Endothelium-Derived Relaxing Factor Activity in Different Artery TypesJournal of Cardiovascular Pharmacology, 1986
- Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1986
- Mechanisms of the ergonovine-induced vasoconstriction in the rabbit main coronary arteryNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1984
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980